0.8132
Precedente Chiudi:
$0.7998
Aprire:
$0.78
Volume 24 ore:
77,925
Relative Volume:
0.57
Capitalizzazione di mercato:
$4.82M
Reddito:
-
Utile/perdita netta:
$-15.52M
Rapporto P/E:
-0.0438
EPS:
-18.58
Flusso di cassa netto:
$-16.61M
1 W Prestazione:
-5.44%
1M Prestazione:
-14.08%
6M Prestazione:
+5.60%
1 anno Prestazione:
-92.26%
Revelation Biosciences Inc Stock (REVB) Company Profile
Nome
Revelation Biosciences Inc
Settore
Industria
Telefono
650-800-3717
Indirizzo
4660 LAJOLLA VILLAGE DRIVE, SAN DIEGO
Confronta REVB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
REVB
Revelation Biosciences Inc
|
0.8132 | 4.74M | 0 | -15.52M | -16.61M | -18.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.13 | 115.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.31 | 81.12B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.17 | 52.54B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
839.99 | 51.78B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.12 | 37.12B | 447.02M | -1.18B | -906.14M | -6.1812 |
Revelation Biosciences Inc Borsa (REVB) Ultime notizie
Published on: 2026-01-01 23:42:59 - bollywoodhelpline.com
Price Action: How Revelation Biosciences Inc stock performs after earnings2025 Support & Resistance & Reliable Momentum Entry Alerts - moha.gov.vn
Viking Therapeutics (NASDAQ:VKTX) and Revelation Biosciences (NASDAQ:REVB) Head to Head Contrast - Defense World
Marshall Machines Limited (MARSHALL) Expands into New MarketTrading Psychology Tips & Low Risk Capital Growth Plans - bollywoodhelpline.com
Revelation Biosciences on track for end-of-phase 1 meeting later this year - MSN
Revelation Biosciences reaches quorum for Dec. 3 special meeting - MSN
Total debt per share of Revelation Biosciences, Inc. – NASDAQ:REVB - TradingView — Track All Markets
Revelation Biosciences, Inc. (REVB) Raises $4M in Public Offering - MSN
Why Revelation Biosciences Inc. stock is favored by pension fundsChart Signals & Free Expert Approved Momentum Trade Ideas - Улправда
Why Revelation Biosciences Inc. stock remains resilientWeekly Gains Summary & Entry Point Strategy Guides - Улправда
Market Recap: What risks investors should watch in Revelation Biosciences Inc. stockMarket Weekly Review & Scalable Portfolio Growth Methods - Улправда
Aug Summary: Will Revelation Biosciences Inc. stock recover faster than marketGap Up & Verified Swing Trading Watchlist - Улправда
How Revelation Biosciences Inc. stock trades before earningsJuly 2025 Big Picture & Short-Term High Return Strategies - DonanımHaber
Is Revelation Biosciences Inc. Equity Warrant stock affected by interest rate hikes - Улправда
Why Revelation Biosciences Inc. stock is a must watch in 20252025 Risk Factors & High Return Trade Guides - DonanımHaber
Is Revelation Biosciences Inc. stock undervalued vs historical averagesMarket Trend Report & Verified Technical Signals - DonanımHaber
Is Revelation Biosciences Inc. Equity Warrant stock a buy for dividend growth2025 Market Trends & Low Risk High Reward Ideas - DonanımHaber
How buybacks impact Revelation Biosciences Inc. stock valueEarnings Miss & Intraday High Probability Alerts - DonanımHaber
Revelation Biosciences Earnings Notes - Trefis
Short Squeeze: How buybacks impact Revelation Biosciences Inc. Equity Warrant stock valuePortfolio Risk Report & Daily Growth Stock Investment Tips - Улправда
Aug Breakouts: What risks investors should watch in Revelation Biosciences Inc. stockWeekly Market Outlook & Real-Time Market Sentiment Reports - Улправда
What risks investors should watch in Revelation Biosciences Inc. stockInsider Buying & Advanced Technical Analysis Signals - Улправда
Recap Report: How buybacks impact Revelation Biosciences Inc. Equity Warrant stock valueEarnings Overview Report & Low Risk Investment Opportunities - Улправда
Will Revelation Biosciences Inc. stock recover faster than marketWeekly Investment Summary & Accurate Technical Buy Alerts - Улправда
Revelation Biosciences, Inc. (REVB) Stock Forecast & Price Prediction 2025–2030 - CoinCodex
Aug Outlook: Why Revelation Biosciences Inc stock appeals to dividend seekersJuly 2025 Reactions & Smart Allocation Stock Tips - moha.gov.vn
Revelation Biosciences sets warrant expiration after stockholder approval By Investing.com - Investing.com Nigeria
Revelation Biosciences sets warrant expiration after stockholder approval - Investing.com
Why Revelation Biosciences Inc. stock remains a top recommendationJuly 2025 PostEarnings & Weekly Watchlist for Hot Stocks - Newser
Revelation Biosciences Has Reached A Quorum For Its December 3, 2025 Special Meeting - azcentral.com and The Arizona Republic
Revelation Biosciences shareholders approve warrant issuance and meeting adjournment By Investing.com - Investing.com Canada
Revelation Biosciences, Inc. (REVB) -5.1% in After-hours: Amid Routine Trading Conditions - Stocks Telegraph
Revelation Biosciences shareholders approve warrant issuance and meeting adjournment - Investing.com
Revelation Biosciences (REVB) Stock Analysis Report | Financials & Insights - Benzinga
Revelation Biosciences (NASDAQ: REVB) secures quorum ahead of Dec. 3 vote, notes $9.6M proceeds - Stock Titan
Revelation Biosciences (NASDAQ:REVB) Shares Up 2.4% – Here’s Why - Defense World
Revelation Biosciences, Inc. (REVB) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
Earnings Flash (REVB) Revolution Beauty Group Reports Fiscal H1 Revenue GBP49.4M - marketscreener.com
Revelation Biosciences Inc. Announces Cancellation of Adjournment of October 29, 2025 Special Meeting of Stockholders and New Record Date - The State Journal-Register
Revelation Biosciences On Track for End-of-Phase 1 Meeting With FDA Later This Year - The Courier-Journal
Can Revelation Biosciences Inc. Equity Warrant stock sustain free cash flow growthLong Setup & Accurate Entry/Exit Alerts - newser.com
How Revelation Biosciences Inc. stock reacts to global recession fearsJuly 2025 News Drivers & High Accuracy Investment Signals - newser.com
Revelation Biosciences submits end-of-phase 1 package to FDA By Investing.com - Investing.com Australia
Revelation Says On Track for FDA Meeting Later This Year - MarketScreener
Revelation Biosciences submits end-of-phase 1 package to FDA - Investing.com
Revelation Biosciences Inc Azioni (REVB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):